当前位置: X-MOL 学术Nat. Rev. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Immunotherapy trials in mesothelioma - promising results, but don't stop here.
Nature Reviews Clinical Oncology ( IF 78.8 ) Pub Date : 2019-12-01 , DOI: 10.1038/s41571-019-0291-4
Anna K Nowak 1, 2, 3 , Patrick M Forde 4
Affiliation  

In the past few years, several studies have addressed the possibility of using immunotherapies to treat patients with mesothelioma. Herein, we discuss two recent trials, one testing the immune-checkpoint inhibitor nivolumab and the other testing a mesothelin-directed therapeutic vaccine, and reflect on the advances and challenges remaining in this research area.

中文翻译:

间皮瘤的免疫治疗试验 - 有希望的结果,但不要止步于此。

在过去几年中,几项研究探讨了使用免疫疗法治疗间皮瘤患者的可能性。在此,我们讨论了最近的两项试验,一项测试免疫检查点抑制剂 nivolumab,另一项测试间皮素导向的治疗性疫苗,并反思该研究领域的进展和挑战。
更新日期:2019-10-17
down
wechat
bug